Logo (USPTO, 10/11/2011)
USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark was filed as Figurative mark on 10/11/2011 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 06/26/2012.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Figurative mark |
| File reference | 85443925 |
| Register number | 4163930 |
| Application date | October 11, 2011 |
| Publication date | April 10, 2012 |
| Entry date | June 26, 2012 |
Trademark owner
No.3 Platform Jinding Tech-Zone
Kunming
CN
Kunming
CN
Trademark representatives
goods and services
5
pharmaceutical preparations and formulations for the treatment of cancer; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for skin care; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations, namely, elixirs for the treatment of cancer; Pharmaceutical preparation for skin care; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating hypertension; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Biochemicial drug, namely, for cancer; Depuratives for the body; Medicines for veterinary purposes; Biological preparations for medical purposes, namely, for cancer; Sterilising preparations; Fungicides; Antibiotics; Allergy capsules; Capsules sold empty for pharmaceuticals; Concentrated saline capsules for sinus and nasal irrigation; Decongestant capsules; Diet capsules; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Nutritional supplements in capsule form for dogs; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Unit dose capsules sold empty for pharmaceutical use
ID: 1385443925